Showing results (381-390 of 654) with videos related to

Sort By:
Pageof 66
NPJ Precision Oncology|February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) studyBlessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Advances in Therapy|March 6, 2025
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02Ana Oaknin, Jung-Yun Lee, Vicky Makker, et al.
Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
JCO Precision Oncology|February 2, 2022
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced CancersBenjamin Garmezy, Jinesh Gheeya, Heather Y Lin, et al.
JCO Precision Oncology|July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced CancersMohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in BRAF V600-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.
Cancer Research|November 3, 2017
"Personalized Cancer Therapy": A Publicly Available Precision Oncology ResourceKatherine C Kurnit, Ann M Bailey, Jia Zeng, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosisEugene H Huang, Eric A Strom, Vicente Valero, et al.
Annals of Surgical Oncology|May 6, 2010
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapyRanjna Sharma, Isabelle Bedrosian, Anthony Lucci, et al.
Pageof 66